Pharmacologic pitfalls in the human tumor clonogenic assay.
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000633:toxicity*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000633:toxicity; D001711:Biotransformation; D002470:Cell Survival / Q000187:drug effects; D003114:Colony-Forming Units Assay; D003520:Cyclophosphamide / Q000378:metabolism; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004355:Drug Stability; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008862:Microsomes, Liver / Q000378:metabolism; D009369:Neoplasms / Q000473:pathology*; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000473:pathology; D051381:Rats; D014410:Tumor Stem Cell Assay
D000970:Antineoplastic Agents; D003520:Cyclophosphamide